Journal article icon

Journal article

Viral vectors as vaccine platforms: Deployment in sight

Abstract:

A little more than a decade after the explosion of research into recombinant live-attenuated or replication-deficient viruses as vaccine platforms, many viral vector-based vaccines have been licensed for animals. Progress has been slower for humans but 2011 will see the licensure of the first viral-vectored vaccine for humans, against Japanese Encephalitis. In addition a vaccine with a viral-vectored component showed efficacy against HIV infection in humans. Viral-based vaccines have an excel...

Expand abstract

Actions


Access Document


Publisher copy:
10.1016/j.coi.2011.03.006

Authors


Rollier, CS More by this author
More by this author
Institution:
University of Oxford
Department:
Oxford, MSD, Clinical Medicine
Cottingham, MG More by this author
Journal:
Current Opinion in Immunology
Volume:
23
Issue:
3
Pages:
377-382
Publication date:
2011-06-05
DOI:
EISSN:
1879-0372
ISSN:
0952-7915
URN:
uuid:282e74ef-103e-4431-b651-1984047cc925
Source identifiers:
162160
Local pid:
pubs:162160
Language:
English

Terms of use


Metrics



If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP